Vasanthy Vigneswara1, Martin Berry, Ann Logan, Zubair Ahmed. 1. Neurotrauma and Neurodegeneration Section, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Abstract
PURPOSE: To investigate neuroprotective and axogenic properties of pigment epithelium-derived factor (PEDF) in retinal ganglion cells (RGC) in vitro and in vivo. METHODS: Adult rat retinal cultures were treated with combinations of PBS and PEDF with or without a cell permeable analogue of cAMP, and RGC survival and neurite lengths quantified. The optic nerves of anesthetised rats were also crushed intraorbitally to transect all RGC axons followed by intravitreal injections of either PBS, PEDF, or cAMP+PEDF every 7 days. RGC were back filled with FluoroGold to quantify RGC survival and longitudinal optic nerve sections were stained with GAP43 antibodies to detect regenerating RGC axons. RESULTS: An optimal dose of 2.5 × 10(-5) μg/μL, promoted 65% more RGC survival than controls in vitro, increasing by 4.4- and 5-fold the number of RGC with neurites and the mean neurite length, respectively. Addition of cAMP with or without PEDF did not potentiate RGC survival or the mean number of RGC with neurites, but enhanced RGC neurite length by 1.4-fold, compared with PEDF alone. After optic nerve crush (ONC), PEDF protected RGC from apoptosis and increased the numbers of regenerating RGC axons in the optic nerve by 4.6- and 3.4-fold, respectively when compared with controls. cAMP did not enhance PEDF-induced RGC neuroprotection, but potentiated its neuroregenerative effects by 2- to 3-fold, increasing the number of RGC axons regenerating at 500 and 1000 μm from the lesions site. CONCLUSIONS: This study is the first to demonstrate that PEDF enhances both RGC survival and axon regeneration in vitro and in vivo.
PURPOSE: To investigate neuroprotective and axogenic properties of pigment epithelium-derived factor (PEDF) in retinal ganglion cells (RGC) in vitro and in vivo. METHODS: Adult rat retinal cultures were treated with combinations of PBS and PEDF with or without a cell permeable analogue of cAMP, and RGC survival and neurite lengths quantified. The optic nerves of anesthetised rats were also crushed intraorbitally to transect all RGC axons followed by intravitreal injections of either PBS, PEDF, or cAMP+PEDF every 7 days. RGC were back filled with FluoroGold to quantify RGC survival and longitudinal optic nerve sections were stained with GAP43 antibodies to detect regenerating RGC axons. RESULTS: An optimal dose of 2.5 × 10(-5) μg/μL, promoted 65% more RGC survival than controls in vitro, increasing by 4.4- and 5-fold the number of RGC with neurites and the mean neurite length, respectively. Addition of cAMP with or without PEDF did not potentiate RGC survival or the mean number of RGC with neurites, but enhanced RGC neurite length by 1.4-fold, compared with PEDF alone. After optic nerve crush (ONC), PEDF protected RGC from apoptosis and increased the numbers of regenerating RGC axons in the optic nerve by 4.6- and 3.4-fold, respectively when compared with controls. cAMP did not enhance PEDF-induced RGC neuroprotection, but potentiated its neuroregenerative effects by 2- to 3-fold, increasing the number of RGC axons regenerating at 500 and 1000 μm from the lesions site. CONCLUSIONS: This study is the first to demonstrate that PEDF enhances both RGC survival and axon regeneration in vitro and in vivo.
Authors: T Kurokawa; N Katai; H Shibuki; S Kuroiwa; Y Kurimoto; C Nakayama; N Yoshimura Journal: Invest Ophthalmol Vis Sci Date: 1999-11 Impact factor: 4.799
Authors: Alberto Hernández-Pinto; Federica Polato; Preeti Subramanian; Andrés de la Rocha-Muñoz; Susan Vitale; Enrique J de la Rosa; S Patricia Becerra Journal: Exp Eye Res Date: 2019-04-10 Impact factor: 3.467
Authors: Sarah K Ohlemacher; Akshayalakshmi Sridhar; Yucheng Xiao; Alexandra E Hochstetler; Mansoor Sarfarazi; Theodore R Cummins; Jason S Meyer Journal: Stem Cells Date: 2016-03-21 Impact factor: 6.277
Authors: Sara M Blazejewski; Sarah A Bennison; Ngoc T Ha; Xiaonan Liu; Trevor H Smith; Kimberly J Dougherty; Kazuhito Toyo-Oka Journal: Cereb Cortex Date: 2022-02-08 Impact factor: 4.861